Journal
CANCER SCIENCE
Volume 103, Issue 12, Pages 2181-2185Publisher
WILEY-BLACKWELL
DOI: 10.1111/cas.12024
Keywords
-
Categories
Funding
- Foundation for Advancement of International Science
- Institute of Asahi-Life Foundation
- [22590679]
- Grants-in-Aid for Scientific Research [22390347, 22590679, 24659027, 23659033, 20229004] Funding Source: KAKEN
Ask authors/readers for more resources
Aside from the human epidermal growth factor receptor-2 (HER2)-targeting agent trastuzumab, molecular targeting therapy for gastric cancer (GC) has not been established. We previously reported that apoptosis signal-regulating kinase-1 (ASK1) was upregulated in human GC and that overexpression of ASK1 promoted GC cell proliferation. Here, we investigated the effect of ASK1 inhibitor K811 on GC cells. K811 efficiently prevented cell proliferation in cell lines with high ASK1 expression and in HER2-overexpressing GC cells. Treatment with K811 reduced sizes of xenograft tumors by downregulating proliferation markers. These results indicate that ASK1 inhibition prevents GC cell growth in vitro and in vivo, suggesting that ASK1 inhibitors can be potent therapeutic drugs for GC. (Cancer Sci 2012; 103: 2181-2185)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available